STOCK TITAN

Tango Therapeutics to Present at the Piper Sandler 36th Annual Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

Tango Therapeutics (NASDAQ: TNGX), a clinical-stage biotechnology company focused on precision cancer medicines, announced that their President of Research & Development, Adam Crystal, M.D., Ph.D., will present at the Piper Sandler 36th Annual Healthcare Conference. The presentation is scheduled for Thursday, December 5, 2024, at 1:30 PM ET. A live webcast will be available on the company's website under the 'Events & Presentations' section, with a replay accessible for 90 days after the event.

Tango Therapeutics (NASDAQ: TNGX), una compagnia biotecnologica in fase clinica focalizzata su medicinali per il cancro di precisione, ha annunciato che il loro Presidente della Ricerca e Sviluppo, Adam Crystal, M.D., Ph.D., presenterà alla 36ª Conferenza Annuale sulla Salute di Piper Sandler. La presentazione è programmata per giovedì 5 dicembre 2024, alle 13:30 ET. Un webcast dal vivo sarà disponibile sul sito web dell'azienda nella sezione 'Eventi e Presentazioni', con una registrazione accessibile per 90 giorni dopo l'evento.

Tango Therapeutics (NASDAQ: TNGX), una compañía biotecnológica en etapa clínica enfocada en medicamentos de precisión para el cáncer, anunció que su Presidente de Investigación y Desarrollo, Adam Crystal, M.D., Ph.D., presentará en la 36ª Conferencia Anual de Salud de Piper Sandler. La presentación está programada para jueves, 5 de diciembre de 2024, a la 1:30 PM ET. Una transmisión en vivo estará disponible en el sitio web de la empresa en la sección 'Eventos y Presentaciones', con una repetición accesible por 90 días después del evento.

탱고 테라퓨틱스 (NASDAQ: TNGX)는 정밀 암 치료제에 집중하는 임상 단계 생명공학 회사로, 아담 크리스탈, M.D., Ph.D. 연구개발 사장이 파이퍼 샌들러 제36회 연례 헬스케어 컨퍼런스에서 발표할 것이라고 발표했습니다. 발표는 2024년 12월 5일 목요일 오후 1:30 ET로 예정되어 있습니다. 생중계는 회사 웹사이트의 '이벤트 및 발표' 섹션에서 제공되며, 이벤트 후 90일 동안 재생할 수 있습니다.

Tango Therapeutics (NASDAQ: TNGX), une entreprise de biotechnologie en phase clinique axée sur les médicaments anticancéreux de précision, a annoncé que son Président de la Recherche et du Développement, Adam Crystal, M.D., Ph.D., fera une présentation lors de la 36e Conférence Annuelle sur la Santé de Piper Sandler. La présentation est prévue pour le jeudi 5 décembre 2024, à 13h30 ET. Une diffusion en direct sera disponible sur le site de l'entreprise dans la section 'Événements et Présentations', avec un replay accessible pendant 90 jours après l'événement.

Tango Therapeutics (NASDAQ: TNGX), ein Biotechnologie-Unternehmen in der klinischen Phase, das sich auf präzise Krebsmedikamente konzentriert, gab bekannt, dass der Präsident für Forschung und Entwicklung, Adam Crystal, M.D., Ph.D., auf der 36. jährlichen Gesundheitskonferenz von Piper Sandler präsentieren wird. Die Präsentation ist für Donnerstag, den 5. Dezember 2024, um 13:30 Uhr ET geplant. Ein Livestream wird auf der Unternehmenswebsite im Abschnitt 'Veranstaltungen und Präsentationen' verfügbar sein, mit einer Wiederholung, die 90 Tage nach der Veranstaltung zugänglich ist.

Positive
  • None.
Negative
  • None.

BOSTON--(BUSINESS WIRE)-- Tango Therapeutics, Inc. (NASDAQ: TNGX), a clinical-stage biotechnology company committed to discovering and delivering the next generation of precision cancer medicines, today announced that Adam Crystal, M.D., Ph.D., President, Research & Development of Tango Therapeutics, is scheduled to present at the Piper Sandler 36th Annual Healthcare Conference on Thursday, December 5, 2024 at 1:30 PM ET.

A live webcast of the presentation will be available under the "Events & Presentations" tab on the “Investors” page on the Company's website on the day of the event. A replay of the webcast will be archived on the Company's website for 90 days following the presentation.

About Tango Therapeutics

Tango Therapeutics is a clinical-stage biotechnology company dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. Using an approach that starts and ends with patients, Tango leverages the genetic principle of synthetic lethality to discover and develop therapies that take aim at critical targets in cancer. For more information, please visit www.tangotx.com.

Investor Contact:

Sam Martin/Andrew Vulis

Argot Partners

tango@argotpartners.com



Media Contact:

Amanda Brown Galgay

SVP, Corporate Communications, Tango Therapeutics

media@tangotx.com

Source: Tango Therapeutics, Inc.

FAQ

When is Tango Therapeutics (TNGX) presenting at the Piper Sandler Healthcare Conference 2024?

Tango Therapeutics (TNGX) is scheduled to present at the Piper Sandler Healthcare Conference on Thursday, December 5, 2024, at 1:30 PM ET.

How long will the Tango Therapeutics (TNGX) Piper Sandler Conference webcast be available?

The webcast replay will be archived on Tango Therapeutics' website for 90 days following the presentation.

Who is presenting for Tango Therapeutics (TNGX) at the Piper Sandler Healthcare Conference?

Adam Crystal, M.D., Ph.D., President of Research & Development at Tango Therapeutics, will be presenting at the conference.

Where can I watch Tango Therapeutics' (TNGX) Piper Sandler Conference presentation?

The presentation can be viewed via live webcast under the 'Events & Presentations' tab on the 'Investors' page of Tango Therapeutics' website.

Tango Therapeutics, Inc.

NASDAQ:TNGX

TNGX Rankings

TNGX Latest News

TNGX Stock Data

400.67M
93.54M
12.84%
100.68%
8.46%
Biotechnology
Pharmaceutical Preparations
Link
United States of America
BOSTON